Pharmacy Drugs
Recent Posts
- EPIX Pharmaceuticals Announces FDA Approval Of A Physician-Sponsored IND For Fourth 6-month Open Label Extension Of PRX-03140 For Alzheimer’s Disease
- Miriam Hospital Researcher Receives More Than $12 Million To Study Weight Control
- Novel HIV Drug To Be Studied In Cell Cultures And Patients
- ISCTM Meeting Discusses Clinical And Regulatory Aspects Of Using Adaptive Designs In Clinical Trials For Central Nervous System Drug Approvals
- Evaluation Of The Cost Effectiveness Of Implantable Blood Pressure Device
Random Posts
- Study Uncovers How Tiny Levels Of Carbon Monoxide Damage Fetal Brain
- Implantable Hearing Aid Gets Nod from FDA Panel
- Approval For Use Of RISPERDAL CONSTA As Both A Monotherapy And Adjunctive Therapy In The Maintenance Treatment Of Bipolar I Disorder Granted By FDA
- PUrsuing Novel Stem-Cell Derived Therapy For Lou Gehrig's Disease With $10.8 Million Award
- First Genetic Evidence For Why Placebos Work Presented By UCLA Scientists
- Autologous Stem Cell Transplantation For Soft Tissue Sarcoma: Insufficient Research Into Therapy
- Study Redefines Placebo Effect As Part Of Effective Treatment
- Immunotherapy Demonstrates Long-Term Success In Treating Lymphoma
- Buy Phentermine Online
- New Therapy Improves Chances Of Living Disease-free With Difficult-to-treat Childhood Cancer
Novel Peripheral IV Catheter: Telesso Technologies Wins Popular Science Invention Award
Posted by: admin in Pharmacy Drugs on November 15th, 2009
Telesso Technologies Limited (ASX: TEO), a global healthcare company, has announced the FDA-approved guide wire-assisted peripheral IV catheter it is developing with Vascular Pathways, Inc., has been honored with the Popular Science Invention Award.
“Telesso is pleased to receive another exciting external validation of this innovative device that may revolutionize peripheral IV placement,” said Telesso’s CEO Nelson K. Stacks. “Attempts to start an IV frequently fail, which is frustrating for clinicians, painful for patients and costly to the health care system. The new guide-wire assisted peripheral IV catheter uses a practical design to improve the ability for clinicians to get it right the first time, creating efficiency, enhancing safety, reducing costs, and avoiding the need for re-sticks.”
A post-market trial is currently comparing patients treated with Telesso’s catheter to the industry’s gold standard device for peripheral IV placement. Data review is expected in Q2-Q3 2009.
About the Guide Wire-Assisted Peripheral IV Cathete
A peripheral vein is the most common site for insertion of a catheter for short-term diagnostic or therapeutic use. The catheter is placed into the peripheral vein in the arm and is typically passed up inside the vein to a length of 2-3 inches. Telesso’s uniquely-designed guide wire-assisted peripheral IV catheter device uses a first-in-class retractable nitinol guide wire system that is believed to enable easier IV access, reduce common safety risks, significantly lessen patient pain and discomfort, and provide cost savings to facilities by lowering administrative costs associated with failed IV starts. Telesso believes this catheter device is the first clinically meaningful advancement in peripheral IV access since automatic needle retraction catheters and addresses significant unmet needs in peripheral intravenous access.
About the Telesso-VPI Agreement
Telesso Technologies Limited announced in December 2008 that it entered into a strategic agreement with Vascular Pathways, Inc. (VPI), a private company based in California, to co-develop VPI’s guide wire-assisted device with the funding of the clinical trial and to potentially acquire VPI.
Source:
Jeff Riley
Cytori Therapeutics
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.